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An ongoing challenge in biomedical research is the search for simple, yet robust assays using 3D 
cell cultures for toxicity screening. This study addresses that challenge with a novel spheroid assay, 
wherein spheroids, formed by magnetic 3D bioprinting, contract immediately as cells rearrange and 
compact the spheroid in relation to viability and cytoskeletal organization. Thus, spheroid size can 
be used as a simple metric for toxicity. The goal of this study was to validate spheroid contraction 
as a cytotoxic endpoint using 3T3 fibroblasts in response to 5 toxic compounds (all-trans retinoic 
acid, dexamethasone, doxorubicin, 5′-fluorouracil, forskolin), sodium dodecyl sulfate (+control), 
and penicillin-G (−control). Real-time imaging was performed with a mobile device to increase 
throughput and efficiency. All compounds but penicillin-G significantly slowed contraction in a dose-
dependent manner (Z’ = 0.88). Cells in 3D were more resistant to toxicity than cells in 2D, whose 
toxicity was measured by the MTT assay. Fluorescent staining and gene expression profiling of 
spheroids confirmed these findings. The results of this study validate spheroid contraction within 
this assay as an easy, biologically relevant endpoint for high-throughput compound screening in 
representative 3D environments.
A major challenge in biomedical research and drug development is predicting in vivo responses to drugs 
in vitro. While most in vitro assays are cheaper and easier to perform than animal testing, they are 
often poorly representative of physiological environments1–7. In vitro assays are typically performed as 
two-dimensional (2D) cell monolayers with rigid substrates and unidirectional biochemical concentra-
tion gradients that inadequately mimic tissue environments found in vivo3–6. Three-dimensional (3D) in 
vitro systems address the shortcomings of 2D systems, offering in vivo-like environments and cell-cell 
and cell-extracellular matrix (ECM) interactions that are crucial to the regulation of cell behavior and 
function but are difficult to replicate in 2D8,9. There are many 3D cell culture systems currently available, 
such as ECM protein gels, hydrogels, and commonly spheroid technologies, like hanging drop cultures, 
round bottom or micropatterned plates10–13. However, these systsems suffer from various technical chal-
lenges that limit their potential. These platforms require long formation times (more than three days to 
form) and difficult handling that limit high-throughput screening, are difficult to image, particularly with 
round bottom plates and hanging drop spheroids, and some cell types may not readily generate sphe-
roids14–16. Furthermore, technical issues with light penetration and reagent diffusion have made assaying 
spheroids difficult17. These shortcomings in 3D environments necessitate the development of simple, yet 
robust endpoints for high-throughput toxicity screening.
Towards that end, this study investigated a novel spheroid assay for toxicity screening. The basis of this 
assay is magnetic 3D bioprinting (M3DB), wherein cells are magnetized with a magnetic nanoparticle 
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assembly consisting of gold, iron oxide, and poly-L-lysine, after which they are easily directed using 
mild magnetic forces18–29. In this assay, these magnetized cells can be rapidly printed using a cylindrical 
magnet to attract cells to form a spheroid at the bottom of a multiwell plate. The nanoparticles and mag-
netic forces used to print spheroids are biocompatible, as reported in previous publications22,23,27,28,30,31. 
In printing the cells, they organize themselves to build a 3D environment that replicates many charac-
teristics of native tissue, particularly cell-cell and cell-ECM interactions. Similar methods have previ-
ously been employed to simulate such tissues as fat23, lung27, aortic valve28, blood vessels21,22, and tumor 
microenvironments, such as that of breast cancer29 and glioblastoma18,19, all of which show in vivo-like 
protein expression and ECM. From this foundation, assays can be developed that take advantage of the 
representative environment of spheroids.
The general principle of this methodology was first demonstrated in the development of a 3D analog 
to the scratch assay26, wherein magnetized cells were printed into a 3D ring. Cells interacted with each 
other and ECM to close the ring as a function of cell migration and proliferation, thereby mimicking 
wound healing26. With M3DB spheroids, building on the principles of the aforementioned ring assay, a 
novel assay was developed utilizing spheroid size and its change because of early events, like compac-
tion32–34, as an endpoint for cytotoxicity. This assay represents an expansion of application into general 
cytotoxicity from the ring assay. After rapidly generating M3DB spheroids and removing the magnetic 
field, spheroids immediately contract in size, as cells rearrange and compact to find an equilibrium size 
from which to grow long term (Fig. 1)32–34. When compounds are added immediately after printing, the 
rate of contraction is varied in a dose-dependent manner, as measured by the change in the projected 
area over time. In the presence of toxic compounds, spheroids contract at a slower rate. Given the large 
size of spheroids and their contrast with media due to their brown color imparted by the nanoparticles, 
their change in size can be imaged at programmed intervals using a mobile device. As a result, spheroids 
can be imaged simultaneously in a multiwell plate, rather than individually under a microscope, thereby 
improving imaging throughput and efficiency26. Thus, spheroid contraction is a unique phenomenon 
that occurs immediately after printing which this assay capitalizes on as an endpoint for cytotoxicity for 
rapid testing and imaging.
The goal of this study was to validate spheroid contraction as a measure of cytotoxicity using 
3T3 murine embryonic fibroblasts, following the recommendations from the National Institute of 
Environmental Health Sciences for the development and validation of cytotoxicity assays35. To validate 
this assay, spheroid contraction was measured using a panel of seven compounds: all-trans retinoic acid 
(ATRA), 5′ -fluorouracil, dexamethasone, doxorubicin, forskolin, sodium dodecyl sulfate (SDS), and 
penicillin-G. The positive control for this assay was SDS, a detergent used to denature proteins and lyse 
cells and a commonly used positive control, and the negative control was penicillin-G, a common anti-
biotic. Toxic responses in spheroid contraction rate were correlated to viability, cytoskeletal organization, 
and gene expression within the spheroids. This assay was then compared to the standard methylthiazolyl 
tetrazolium (MTT) assay performed on 2D cultures, which is commonly used for cytotoxic screens36. The 
results of this study help demonstrate that this assay using M3DB spheroids can overcome the technical 
limitations in speed, throughput, handling, and imaging of other 3D cell culture platforms to offer a 
simple yet robust assay for the determination of general cytotoxicity in a 3D environment.
Results
Spheroid Toxicity Assay. 3T3 cells were successfully printed into spheroids whose dose-dependent 
contraction was imaged over time using a mobile device-based imaging system. Image analysis showed 
that over the course of 10 h, the 3T3 spheroids contracted except when exposed to penicillin-G, the 
negative control (Fig. 2, see Supplemental Movie M1 for a movie of spheroid contraction in response to 
ATRA). The cytotoxic endpoint was the rate of spheroid size change over the first 150 min. There was a 
significant separation in contraction (p < 0.05) between the vehicle (phosphate buffered saline, PBS) and 
the high concentration of the positive control (625 μ M SDS), from which a Z’ of 0.88 was calculated37. 
Overall, there was a significant (p < 0.05) dose-dependent effect on spheroid contraction rate for all com-
pounds from which half-maximal inhibitory concentrations (IC50) were calculated, except penicillin-G 
(Table 1). Overall, spheroids exposed to higher concentrations contracted at a slower rate than spheroids 
exposed to lower concentrations (see Supplemental Fig. S1-2 for the kinetic and dose-response curves of 
3T3 spheroids with other compounds).
Fluorescent Staining. Spheroids contracted for 72 h were fixed and fluorescently stained to assess 
viability and cytoskeletal organization (Fig.  2 for 3T3s exposed to ATRA, see Supplemental Figs S3-4 
for viability and cytoskeletal staining of spheroids exposed to other compounds). In parallel to the com-
pounds’ effects on contraction, at higher compound concentrations the spheroids were less viable, and 
exhibited a looser cytoskeletal organization, as demonstrated by the increase in dead cells and the dis-
tance between cells.
Spheroid Contraction v. MTT Assay. The results of the spheroid contraction assay were compared 
to that of the MTT assay performed in 2D using the same cells and compounds, where cell viability 
was assessed after 72 h (Fig. 2 for 3T3s exposed to ATRA, see Supplemental Fig. S5 for results with the 
other compounds). IC50 values were indeterminable for 5′ -fluorouracil and dexamethasone given that 
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no significant effect of either compound on viability in 2D was found (Table  1). In general, spheroids 
were more resistant to the toxic effects of the compounds than 2D cultures, with significant differences 
found between their responses in both environments to ATRA, doxorubicin, dexamethasone, SDS, and 
penicillin-G (p < 0.001).
Gene Expression Profiling. The gene expression of 3T3s in 3D was profiled and compared with that 
of 3T3s grown in 2D to elucidate the differences between culture environments (Fig. 3). Of the 364 genes 
whose expression was profiled, 92 genes had significant differences in expression between 3T3s grown in 
2D versus 3D. Of those genes with significant differences, 21 genes were related to apoptosis, with 14 of 
those genes exhibiting reduced expression in 3D. Within the 8 genes which are related to retinol metab-
olism, 2 had lower expression levels in 3D. Of the 63 genes related to regulation of the actin cytoskeleton, 
51 genes were downregulated in 3D cultures as compared to 2D monolayers.
In parallel, 3T3 spheroids with and without 72 h exposure to 41.6 μ M ATRA were profiled to analyze 
the effect of ATRA in 3D (Fig. 3). A concentration of 41.6 μ M was chosen because spheroid contraction 
Figure 1. Magnetic 3D bioprinting. (a) Cells grown to 70-80% confluence in 2D were incubated overnight 
with magnetic nanoparticles (NanoShuttle, NS). After resuspending and levitating the cells for a few hours, 
the cells and ECM were distributed evenly into the wells of a 96-well plate. The cells were then printed for 
15 min by putting the plate atop a 96-well magnetic drive. After printing, the magnet was removed and the 
spheroid contracts. (b) Spheroid contraction over 6 h as cells rearrange and compact. (nuclei = blue). (c) The 
mobile device-based imaging system, with the 96-well plate full of spheroids placed above the mobile device, 
which was set to image the whole plate at programmed intervals as short as 1 s. Scale bar = 250 μ m.
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was affected at and above that concentration. Gene analysis expression showed that 99 genes were 
expressed differently between 3T3 spheroids that were exposed to ATRA and those that were not, with 
27 genes related to apoptosis, 8 related to retinol metabolism, and 64 related to actin regulation. A total of 
40 genes were downregulated as a function of exposure to ATRA, with 15 related to apoptosis, 3 related 
to retinol metabolism, and 22 related to actin regulation.
In comparison to a published dataset in literature on the effect of ATRA on mice38, 11 genes were 
significantly affected by ATRA both in 3D and in vivo, of which 8 had similar effects while 3 had opposite 
effects between the two environments (see Supplemental Fig. S6). Three of those genes were related to 
apoptosis, 1 gene was related to retinol metabolism, and 7 of those genes were related to actin regulation.
Between the two comparisons examined in this study (2D versus 3D, in the presence and absence 
of exposure to ATRA in 3D), a total of 52 common genes showed significant differences in expression, 
12 related to apoptosis, 5 related to retinol metabolism, 35 related to actin regulation. Of those genes, a 
total of 36 genes showed an opposite effect when ATRA was added compared to the effect of transition-
ing from a 2D to 3D environment, with 7 related to apoptosis, 5 related to retinol metabolism, and 24 
related to actin regulation.
Discussion
The goal of this study was to validate contraction of M3DB spheroids as a measure of cytotoxicity. 
Spheroid contraction is a unique endpoint in which viable cells rearrange and compact immediately after 
printing as a result of cell-cell interactions to contract the spheroid into a smaller size as a starting point 
for long-term growth (Fig. 1). When compounds are added at this early stage, the spheroids contract in a 
dose-dependent manner. There is a relationship between spheroid contraction and cell health, which was 
Figure 2. Spheroid contraction of 3T3s in response to ATRA. (a) 3T3 spheroids before and 5 h after 
adding ATRA, as captured by the mobile device (left), live/dead staining (center; live = green, red = dead), 
and cytoskeletal staining using phalloidin for F-actin (right; F-actin = red, nuclei = blue) of spheroids after 
72 h. Black scale bar = 5 mm, white scale bar = 250 μ m. (b) Kinetics of spheroid contraction. (c) The rate of 
contraction of 3T3 spheroids over 150 min (black) as a function of ATRA concentration and compared to 
the viability of 3T3s in 2D (red) as measured by the MTT assay. All values are normalized to control. Error 
bars represent standard deviation. *,#:p < 0.05 compared to control. With higher amounts of ATRA, 3T3 
spheroids contracted less, were less viable, and showed a more disorganized cytoskeleton.
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confirmed in this study, as M3DB spheroids that contracted less with higher compound concentrations 
showed lower viability and looser cytoskeletal organization (Fig. 2). 3T3s were also found in this study to 
be more resistant to compound toxicity in 3D than they were in 2D, with significant differences in gene 
expression for actin regulation found (Fig. 3). These results validate spheroid contraction as a biologically 
meaningful endpoint of cytotoxicity in a 3D environment.
The important result of this study is the correlation of spheroid contraction to viability, cytoskeletal 
organization and apoptosis (Figs 2 & 3). Both SDS (positive control) and penicillin-G (negative control) 
had their intended effects in either inhibiting contraction or not affecting contraction. A Z’ of 0.88 
was found between phosphate buffered saline (PBS, vehicle control) and 625 μ M SDS, where values 
0.5 ≤ Z’ < 1 indicate a large separation between controls that reflects excellent assay quality37. Fluorescent 
staining revealed that spheroid contraction closely matched viability, similar to previous results in M3DB 
rings26. Gene expression analysis demonstrated differences between spheroids in the presence or absence 
of ATRA that support findings of toxicity. Specifically, increased expression of p53 (TRP53), a key pro-
tein promoting apoptosis39, and decreased expression of inhibitors of apoptosis (BCL2, BIRC2, BIRC3)40 
match previous results on the role of ATRA in inducing apoptosis41. Fluorescent staining also revealed 
an effect of ATRA on cytoskeletal organization, which supports previous results on the effect of ATRA 
in disorganizing actin42. Moreover, ATRA affected a large number of genes that regulate actin. In com-
paring spheroids to in vivo tissue, ATRA had similar effects on 8 genes out of 11 genes significantly 
affected in both environments (see Supplemental Fig. S6)38,43. Overall, these results demonstrate that 
toxic responses, such as from ATRA, can be seen in spheroid contraction, and reflect spheroid viability, 
organization, and gene expression similar to in vivo results38.
This study also confirmed that cells in 2D and 3D exhibit significant differences. Cells in 3D had a 
rounder morphology4 (Fig. 1) and a wider array of cell-cell and cell-ECM interactions3–6, which mimic 
physiological environments. Gene expression profiling showed that a majority of genes related to regu-
lation of the actin cytoskeleton were downregulated in 3D (Fig. 3), likely because cells were not growing 
on a stiff substrate and retained a more spherical morphology4. Such differences were previously reported 
in magnetically levitated 3D cultures, where cells maintained their phenotype, function, and synthesized 
ECM18,23,28. Cells in 3D also vary in exposure to molecules between cells on the exterior and cells in 
the interior, as opposed to cells in 2D, where cells have uniform exposure44. This was confirmed in this 
study when comparing this spheroid assay with the MTT assay, where 3T3s in 3D were found to be more 
resistant to compounds relative to 2D (Fig.  2), which maybe associated with different exposure to the 
compound as a function of cellular architecture44. The difference in response is stark with penicillin-G, 
the negative control, which had no effect on spheroid contraction at higher concentrations as expected, 
but did have an effect on monolayers, albeit at very high concentrations, with an IC50 of 5.73 mM listed 
in the NIEHS registry of cytotoxicity35. The disparity in drug resistance is supported by literature, in 
which only forskolin had a higher IC50 in 2D than in this spheroid toxicity assay (Table 1)16,35,45,46. The 
compounds’ IC50’s rank similarly between spheroids and cells in 2D in toxicity, but compared to 2D 
values found in literature, there was a different rank, as forskolin was the most potent compound with 
spheroids, but dexamethasone was found the be the most potent in literature45. Dexamethasone has been 
shown to reduce expression for the integrin subunit β 247, and given the increase in expression of ITGB2 
Compound
3D 2D
Spheroid Assay 
IC50 (μM)
MTT IC50 
(μM) Literature IC50 (μM)
Endpoint
Rate of 
contraction over 
150 min
Viability at 
72 h
ATRA 82.8 24.7 20 (Seiler et al., 2011)16
Dexamethasone 84.6 n.s. 2.77 × 10
−3 (Nakada et 
al., 1987)45
Doxorubicin 46.7 12.7 0.33 (NIEHS Registry of Cytotoxicity)35
5′ -fluorouracil 253 n.s. 2.6 (NIEHS Registry of Cytotoxicity)35
Forskolin 4.7 0.6 26 (Varrault et al., 1992)46
SDS (positive control) 281.8 167.2 270 (NIEHS Registry of Cytotoxicity)35
Penicillin-G (negative control) n.s. 1769.3 5730 (NIEHS Registry of Cytotoxicity)35
Table 1.  IC50 values of compounds tested on 3T3s using the spheroid toxicity assay, or in monolayers 
using the MTT assay. These results were then compared to those IC50 values, reported in literature16,35,45,46. 
n.s. = not significant.
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Figure 3. Gene expression profiles of spheroids. Genes related to apoptosis, retinol metabolism, and actin 
regulation with significant differences (q < 0.05) in expression were assessed between 3T3s in 2D or 3D, and 
3T3 spheroids in the absence or presence of 41.6 μ M ATRA. In transitioning from 2D to 3D, the majority of 
genes whose expression level significantly changed were reduced, largely in genes related to actin regulation. 
41.6 μ M ATRA induced upregulation of the gene for p53, a key protein in apoptosis, and downregulation of 
genes for key apoptotic inhibitors (BCL2, BIRC2, BIRC3), suggesting that exposure to ATRA leads to lesser 
spheroid contraction via increased apoptosis. Green indicates an increase in gene expression, red indicates a 
decrease, with darkness indicating the magnitude of change and gray indicating no significant difference.
www.nature.com/scientificreports/
7Scientific RepoRts | 5:13987 | DOi: 10.1038/srep13987
in 3D compared to 2D, dexamethasone should have a larger effect on 3D cultures with more β 2 subunits, 
and thus the difference in potency rank is reasonable. These results suggest that dimensionality plays a 
role in compound efficacy, and highlight the importance of assaying compounds in 3D.
What makes spheroid contraction a unique endpoint is that it is simple, biologically relevant, and 
label-free. Generally, 3D cell cultures are dense in cells and proteins, and data from the center of the 
spheroid are difficult to capture with reagent-based assays and microscopy17. Spheroid contraction 
escapes these limitations by capturing a culture-wide response through macroscopic imaging without 
any special reagent or dye. This was demonstrated by the differences between spheroid contraction 
and viability in 3T3 spheroids measured by the MTT assay, which was unable to resolve differences in 
any compound except for ATRA, SDS, and penicillin-G (see Supplemental Fig. S7). Moreover, while 
reagent-based assays typically capture only a single endpoint, spheroid contraction can be captured in 
real-time, yielding a time-dependent response that could reveal more information about toxic mecha-
nisms or drug interactions. Reagent-based assays or immunostaining can instead be used to supplement 
spheroid contraction to further explore mechanisms of toxicity, without interference from the magnetic 
nanoparticles. This attribute was demonstrated in this study with fluorescent staining and gene expres-
sion profiling being performed in addition to spheroid contraction. Taken together, spheroid contraction 
is a robust endpoint for cytotoxicity in 3D, while being amenable to other assays for high-content testing.
Additionally, a mobile device-based imaging system was used in this study for automated image 
capture. This system is possible given the contrast between the magnetized cells and media (Fig. 2), and 
the computing power of commercially available mobile devices26. A distinct advantage of this system 
is the ability to image whole plates of spheroids at programmed intervals as small as 1 s, avoiding the 
need to image individual spheroids under a microscope26. With rapid printing, immediate contraction 
and imaging in less than 3 h, and automated analysis to measure contraction in thousands of images 
in hours, this assay can be reasonably executed within 24 h. Overall, the mobile device-based imaging 
system was successfully implemented in this study and demonstrated its efficiency and throughput for 
spheroid toxicity screening.
Another advantage of this system is the presence of ECM within the spheroid. After levitation and 
printing, when the compound is added and the magnet is removed, the cells are loosely connected 
with ECM. This was demonstrated by the presence of laminin and fibronectin in the spheroid, and 
their growth with longer levitation (see Supplemental Fig. S8) and printing times (see Supplemental Fig. 
S9-10). The spheroids were dense enough to respond differently than cells in 2D. Some cases may require 
more ECM in spheroids before exposure to toxic compounds, for which spheroids can be left on the 
magnet for longer to allow spheroids to build ECM (see Supplemental Fig. S9-10). Thus, levitation and 
printing can be varied to allow for more mature spheroids.
The spheroid toxicity assay of this study is based on a previously published assay using similar work-
flows and imaging to assay 3D rings made using magnetic 3D bioprinting26. This spheroid assay builds 
on the ring assay in several ways. First, the main difference between the ring and spheroid assays is the 
shape, wherein spheroids require far less cells (7.5 × 104 cells/spheroid v. 2 × 105 cells/ring). In requiring 
far less cells, the spheroid assay improves upon the cost of the ring assay, and can be more easily extended 
to higher throughput formats (384- and 1536-well plates). These different shapes also model different 
scenarios. Ring closure is akin to a scratch assay, where cell monolayers are injured with a circular void 
or linear scratch that cells will close over time48, and could similarly be used to assay wound healing 
responses in 3D. Spheroid contraction expands on the ring assay’s application to model general cyto-
toxicity, and the ability of cells to migrate, interact with other cells and compact to form the spheroid. 
Thus, while this spheroid assay carries some of the general attributes as the ring assay, its modeling of 
general cytotoxicity and high-throughput format improves upon the ring assay and further addresses 
unmet needs in this field.
In conclusion, this study used M3DB to rapidly print and assay spheroids, which contract as a 
function of migration, compaction, and cell-cell interactions. Spheroid contraction was tracked using 
a mobile device-based imaging system, and was validated as a measure of cytotoxicity. The minimal 
workflow of this assay meets the demand for simple endpoints in high-throughput compound screen-
ing. Moreover, immunohistochemistry and genomic analysis demonstrated that these spheroids are 
amenable to high-content testing. The resulting assay offers a simple, rapid, and robust endpoint for 
high-throughput cytotoxicity screening in representative 3D environments.
Materials and Methods
Cell Culture. 3T3 murine embryonic fibroblasts were cultured in Dulbecco’s Modified Eagle Medium 
(ScienCell, Carlsbad, CA) with 10% fetal bovine serum (Access Biologicals, Vista, CA) and 1% penicillin/
streptomycin (Sigma-Aldrich, St. Louis, MO). Cells were cultured in a humidified environment (37°C, 
5% CO2) with media exchanged every other day.
Compounds. The following compounds were tested in this study (all purchased from Sigma-Aldrich): 
ATRA, 5′ -fluorouracil, forskolin, doxorubicin, dexamethasone, SDS, and penicillin-G. SDS and 
penicillin-G served as the positive and negative controls, respectively, for this assay. The compounds 
were prepared in either (maximum final concentration in parentheses): 1% dimethyl sulfoxide (DMSO, 
Sigma-Aldrich) for ATRA (166.42 μ M) and dexamethasone (509.60 μ M); or PBS (pH~7.4, Sigma-Aldrich) 
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for doxorubicin (100 μ M), 5′ -fluorouracil (256 μ M), forskolin (10 μ M), SDS (625 μ M), and penicillin-G 
(5.98 mM). Vehicle controls were exposed to the solvent alone and tested for each compound, with its 
analysis being conducted separately from that of other vehicle controls with the same solvent.
Spheroid Toxicity Assay. The spheroid toxicity assay was designed to rapidly assess toxicity in M3DB 
spheroids (Fig.  1A)26. At 70–80% confluence, 3T3s grown in 2D were statically incubated overnight 
with magnetic nanoparticles, allowing for nanoparticle association with the cells (NanoShuttle, Nano3D 
Biosciences, Houston, TX) at a concentration of 1 μ L/1 × 104 cells (50 pg/cell)18,25. Cells were magnetized 
by the electrostatic and non-specific attachment of nanoparticles to the cell membrane via poly-L-lysine. 
Once attached onto the membrane, the nanoparticles remain for 7–8 d before releasing into the ECM18. 
If internalized, the nanoparticles will exit the cell still attached to the membrane. These nanoparticles, 
along with the magnetic fields, have been shown to have no effect on cell proliferation18,22,23, viability26, 
metabolism27,28, and inflammatory27 and oxidative28 stress.
After magnetization, the cells were enzymatically detached with trypsin, resuspended in media, 
then distributed into ultra-low attachment 6-well plates (Corning, Tewksbury, MA) at a concentration 
of 3.2 × 106 cells in 2 mL (1.6 × 106 cells/mL). A magnetic drive of 6 neodymium magnets (Nano3D 
Biosciences) was placed atop the well plate to levitate the cells in 3D (500 G, 30 pN, see Supplemental 
Fig. S12). The purpose of this levitation step was to induce ECM formation, as was shown previously 
with primary human pulmonary fibroblasts and tracheal smooth muscle cells that extruded laminin 
after 1 h of levitation27. Moreover, immunohistochemical staining for fibronectin and laminin in 3T3s 
with varying levitation times demonstrates that the longer 3T3s levitate, the more ECM is produced 
(see Supplemental Fig. S8-10). After 1 h of levitation, the levitated cultures were broken up and resus-
pended in media using pipette action to yield a suspension of magnetized cells and ECM, which was 
distributed into an ultra-low attachment 96-well plate (Corning) at a concentration of 7.5 × 104 cells/well 
(n = 3 per compound concentration). Immediately afterwards, the plate was placed atop a magnetic drive 
of 96 neodymium magnets (0.0625” OD, Nano3D Biosciences) to attract the cells (120 G, 10 pN, see 
Supplemental Fig. S12) and ECM to the bottom of the well to form a spheroid. These spheroids were 
printed on the magnets for 15 min. At this point, the cells within the spheroids were connected but loose, 
and their competency could be empirically assessed by their ability to stay together when the magnet was 
removed. Towards the end of the printing time, compounds were added to the wells achieve their final 
concentrations. The plate was then removed from the magnet and the spheroids were allowed to contract.
Mobile Device-Based Imaging and Analysis. M3DB spheroids and their contraction were imaged 
using a mobile device-based imaging system (Fig.  1B)26. After printing, the plate of spheroids were 
placed atop an acrylic imaging apparatus with a mobile device (iPod touch 5th generation, 16 GB, Apple 
Computer, Cupertino, CA) below the plate facing upwards, and a light source (LightPad A920, Artograph, 
Delano, MN) above the plate to illuminate the images. The mobile device was programmed using an 
application (Experimental Assistant, Nano3D Biosciences) to image the plate every 4 min for a period 
of 10 h. When the spheroids had finished contracting, the images were transferred to a computer where 
they were analyzed using a custom image analysis code written in Python that processed thousands of 
images in hours26. The area of the spheroid was measured over time, as well as the rate of contraction for 
the first 150 min using a linear least-squares fit (OriginPro, OriginLab, Northampton, MA). The rates of 
contraction served as the endpoint for the assay, and were plotted against compound concentration and 
fit to a Boltzmann sigmoidal function (OriginPro) from which the IC50’s were determined.
Fluorescent Staining. After spheroid contraction for 72 h, fluorescent staining was performed to 
assess viability and cytoskeletal organization within the spheroids. Throughout staining, spheroids were 
anchored to the bottom of the well plate using the 96-well magnetic drive. Spheroids stained for viabil-
ity (Live/Dead, Biotium, Hayward, CA) were first gently washed with PBS using a multichannel pipet, 
after which, a solution containing 2 μ M calcein AM and 4 μ M ethidium homodimer-III was added to 
each well to incubate for 30 min. The spheroids were then washed again with PBS and imaged under a 
fluorescent microscope.
Spheroids stained for cytoskeletal organization were fixed with 4% paraformaldehyde (Electron 
Microscopy Sciences, Hatfield, PA) for at least 5 h. After washing twice with PBS, a solution contain-
ing fluorescently-tagged phalloidin (AlexaFluor, Invitrogen, Carlsbad, CA) in PBS was added to each 
well for 30 min to stain for F-actin. The spheroids were then washed with PBS and counterstained with 
4′ ,6-diamidino-2-phenylindole (DAPI, KPL, Gaithersburg, MD) for 15 min. After one final wash, the 
spheroids were imaged under a fluorescent microscope.
Spheroids were also stained for nuclei to visualize contraction after printing. Spheroids were printed 
and fixed with 4% paraformaldehyde 0, 1, 3, and 6 h after printing for at least 5 h. After washing twice 
in PBS, the spheroids were stained for nuclei with DAPI for 15 min, then imaged under a fluorescent 
microscope.
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MTT Assay. The MTT assay was performed to compare its endpoint, viability of 3T3s in 2D after 72 h, 
with spheroid contraction. 3T3s were seeded on 96-well plates (n = 3 per compound concentration) at a 
concentration of 2.5 × 104 cells/well to adhere overnight. The following day, compounds were added to 
each well at the desired concentration. After 72 hours of incubation, the media was replaced with 10% 
MTT (Sigma-Aldrich) in media. The cells were incubated with the reagent for at least 4 hours at 37 °C. 
Following incubation, the media was aspirated and the remaining formazan was dissolved in acidified 
isopropanol (0.1 N HCl). The absorbance of the solution was then read at 570 nm in a spectrophotom-
eter (SpectraMax Plus 384, Molecular Devices, Sunnyvale, CA) with background subtraction at 690 nm. 
Dose-response curves were plotted and fit to a Boltzmann sigmoidal function (OriginPro) similarly to 
the spheroid toxicity assay.
Gene Expression Profiling. 3T3 spheroids were exposed to 41.6 μ M ATRA and contracted for 5 h, 
then snap frozen in − 20 °C overnight to lyse the cells. 3T3s in 2D were also cultured for 72 h and fro-
zen. 3T3s in 2D exposed to 41.6 μ M ATRA lysed before 72 h and thus RNA could not be isolated from 
those samples. Total RNA was isolated from the frozen samples of (RNeasy Mini kit, Qiagen, Venlo, 
Netherlands) following manufacturer’s instruction without on-column DNase treatment. Magnetic nan-
oparticles were removed in this process as previously described in literature28. mRNA sequencing was 
conducted for gene expression profiling. The RNA library of each sample was prepared using a direc-
tional mRNA-Seq sample preparation kit (Illumina, San Diego, CA). Single-end reads of 50 nt were 
generated for each sample (HiSeq 200, Illumina). The reads were mapped to genomes (hg19, mm9, and 
rn4 respectively) using Tophat v1.4.149 and assembled with Cufflinks v2.2.150.
Statistical Analysis. Statistical analysis for spheroid contraction and the MTT assay was performed 
with one way analysis of variance (ANOVA) tests (OriginPro). Post hoc Tukey’s testing was performed 
to observe groupwise comparisons for those compounds with significant effects of concentration. The 
Cuffdiff module of Cufflinks was used for differential expression analysis51. Specific categories of genes 
(apoptosis, retinol metabolism, and actin regulation) were selected to generate the heatmap. Significance 
was defined as p, q < 0.05.
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